It is a pharma private limited company based in Pune, Maharashtra, India, established in 2021.
2021 | Pune, Maharashtra, India | ActiveMeditm Pharmaceuticals Private Limited, a active private limited company, was established on 27 September 2021 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U85100PN2021PTC204643. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Suraj Sudhir Mutkule (Director), Priyanka Namdev Amle (Additional Director). Past directors included Avinash Ramchandra Sonalkar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sr No.59/2, Fl No 302-A Wing,Lake Homes Jambhulwadi Bridge, Ambegaon Kh Pune, Pune, Maharashtra, 411046.
U85100PN2021PTC204643
204643
27 September 2021
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Meditm Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suraj Sudhir Mutkule | Director | 27 Sep 2021 | Current |
| Priyanka Namdev Amle | Additional Director | 27 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Meditm Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1007.66% increase. The company also saw a substantial improvement in profitability, with a 150% increase in profit. The company's net worth Soared by an impressive increase of 16.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Meditm Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Meditm Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Meditm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditm Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Meditm Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Meditm Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Priyanka Namdev Amle was appointed as a Additional Director was appointed as a Additional Director on 27 Mar 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
Progress on Suraj Sudhir Mutkule was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 3 months . was documented.
Progress on Meditm Pharmaceuticals Private Limited was registered on 27 Sep 2021 with Roc Pune & aged 4 years 3 months as per MCA records. was documented.
The CIN of Meditm Pharmaceuticals Private Limited is U85100PN2021PTC204643.
Meditm Pharmaceuticals Private Limited is headquartered at Sr No.59/2, Fl No 302-A Wing,Lake Homes Jambhulwadi Bridge, Ambegaon Kh Pune, Pune, Maharashtra, 411046.
Meditm Pharmaceuticals Private Limited was incorporated on 27 September 2021.
The current directors of Meditm Pharmaceuticals Private Limited are
The primary industry of Meditm Pharmaceuticals Private Limited is Manufacturing.
Meditm Pharmaceuticals Private Limited is unlisted.
The authorized capital of Meditm Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX